Rankings
▼
Calendar
NAGE Q3 2018 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$393M
Q3 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
+33.5% YoY
Gross Profit
$4M
53.7% margin
Operating Income
-$9M
-105.9% margin
Net Income
-$9M
-106.0% margin
EPS (Diluted)
$-0.16
QoQ Revenue Growth
+4.1%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$47M
Total Liabilities
$14M
Stockholders' Equity
$33M
Cash & Equivalents
$28M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$6M
+33.5%
Gross Profit
$4M
$3M
+49.6%
Operating Income
-$9M
-$3M
-170.7%
Net Income
-$9M
$2M
-502.7%
← FY 2018
All Quarters
Q4 2018 →